Large-scale isolation of flavonolignans from Silybum marianum extract affords new minor constituents and preliminary structure-activity relationships.
暂无分享,去创建一个
[1] R. Agarwal,et al. Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: Comparison with silymarin and silibinin , 2008, International journal of cancer.
[2] R. Agarwal,et al. Multitargeted therapy of cancer by silymarin. , 2008, Cancer letters.
[3] R. Agarwal,et al. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells , 2008, International journal of cancer.
[4] R. Agarwal,et al. Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway , 2008, Oncogene.
[5] R. Agarwal,et al. Gram-scale purification of flavonolignan diastereoisomers from Silybum marianum (Milk Thistle) extract in support of preclinical in vivo studies for prostate cancer chemoprevention. , 2007, Planta medica.
[6] R. Agarwal,et al. Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells. , 2007, Carcinogenesis.
[7] N. Oberlies,et al. Milk Thistle Nomenclature: Why It Matters in Cancer Research and Pharmacokinetic Studies , 2007, Integrative cancer therapies.
[8] B. Aggarwal,et al. Anticancer potential of silymarin: from bench to bed side. , 2006, Anticancer research.
[9] R. Agarwal,et al. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. , 2005, Cancer research.
[10] Nam-Cheol Kim,et al. Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum). , 2003, Organic & biomolecular chemistry.